$HIMS trading under $40 still doesn’t make sense to me. Billions in annual revenue and still growing fast. The platform is expanding globally, peptides could open another major opportunity, Wegovy sales are exploding . Yet the stock is still priced like growth is slowing and the long term story is broken. What am I missing? 🤔
在 X 查看 ↗